Vivity extended depth of focus (EDOF) intraocular lens (IOL) is the number one most implanted EDOF worldwide, with over one million implants.1-2*
It is the first and only extended depth of focus IOL that uses Wavefront Shaping (X-Wave) technology to create a continuous extended focal range that provides patients with excellent distance, intermediate, and functional near vision.3-5 Vivity provides a visual disturbance profile comparable to a monofocal IOL, and meets and exceeds the American National Standards Institute (ANSI) standards for the EDOF category of IOLs.5-8 Available on Clareon for excellent clarity and stability on Alcon’s most advanced IOL platform to date.9**
Contact: Alcon Laboratories (AUS) 1800 224 153 or (NZ) 0800 101 106
References
- Market Scope – 2023 premium cataract surgery market report; 2023 IOL market report.
- Alcon Data on File, 2024. REF-23554.
- Alcon Data on File, US Patent 9968440 B2, 15 May 2018.
- Kohnen T, et al. Clin Ophthalmol. 2023 Aug 18;17:2449-2457. doi: 10.2147/OPTH.S400083.
- Bala C, et al. J Cataract Refract Surg. doi: 10.1097/j.jcrs.0000000000000712.
- Clareon Vivity extended vision IOL directions for use.
- McCabe C, et al. J Cataract Refract Surg. doi: 10.1097/j. jcrs.0000000000000978.
- American National Standard for Ophthalmics – Extended depth of focus intraocular lenses 2019.
- Werner L, et al. J Cataract Refract Surg. doi: 10.1016/j.jcrs.2019.05.017.
*Based on worldwide sales of AcrySof IQ Vivity and Clareon Vivity IOLs.
**Clinical studies were performed on the AcrySof IQ Vivity IOL; AcrySof IQ Vivty, and Clareon Vivity are optically equivalent.6
